Ginsenoside chemotherapy

Details Ginsenoside chemotherapy Ginsenoside chemotherapy

A - Human Necessities

61

K

A61K 31/337 (2006.01) A61K 31/135 (2006.01) A61K 31/57 (2006.01) A61K 31/7004 (2006.01) A61K 33/24 (2006.01) A61P 31/00 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2307393

The invention provides for the use of ginsenoside Rh2 in pharmaceutical compositions used in methods of inhibiting the multiplication of cancer cells, and methods of treating cancer in patients, comprising administering to such patients therapeutically and synergistically effective amounts of Rh2 in combination with a chemotherapeutic selected from the group consisting of paclitaxel and mitroxantrone. the cancer cells to be treated may be multidrug resistant. The cancer cells may for example be prostate cancer cells or breast cancer cells.

Affiliated with

Also associated with

Rating

Ginsenoside chemotherapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ginsenoside chemotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ginsenoside chemotherapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1685127